Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) - A megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 33-40

  Muth, Michaela ^a   Engelhardt, Bianca M ^a   Kröger, Nicolaus ^b   Hussein, Kais ^a   Schlué, Jérôme ^a   Büsche, Guntram ^a   Kreipe, Hans H ^a   Bock, Oliver ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Biomarker; Megakaryocytes; Primary myelofibrosis; Thrombospondins

Indexed keywords

ENDOGLIN; GENE PRODUCT; JANUS KINASE 2; PROTEIN MPL; RETICULIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER STAGING; CELL LABELING; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOUBLE IMMUNOFLUORESCENCE STAINING; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELOID METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; BONE MARROW; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MEGAKARYOCYTES; MIDDLE AGED; PRIMARY MYELOFIBROSIS; REGISTRIES; THROMBOCYTHEMIA, ESSENTIAL; THROMBOSPONDIN 1; YOUNG ADULT;

EID: 78651274328     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1024-z     Document Type: Article

References (26)

1. A Tefferi 2005 Pathogenesis of myelofibrosis with myeloid metaplasia J Clin Oncol 23 33 8520 8530 10.1200/JCO.2004.00.9316 1:CAS:528:DC%2BD2MXhtlWhtrfP 10.1200/JCO.2004.00.9316 16293880
2. SO Ciurea D Merchant N Mahmud T Ishii Y Zhao W Hu E Bruno G Barosi M Xu R Hoffman 2007 Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis Blood 110 3 986 993 10.1182/blood-2006-12-064626 1:CAS:528:DC%2BD2sXos1Cqsbc%3D 10.1182/blood-2006-12-064626 17473062 (Pubitemid 47267438)
3. JJ Lataillade O Pierre-Louis HC Hasselbalch G Uzan C Jasmin MC Martyre MC Le Bousse-Kerdiles 2008 Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence Blood 112 8 3026 3035 10.1182/blood-2008- 06-158386 1:CAS:528:DC%2BD1cXht1OmtbfP 10.1182/blood-2008-06-158386 18669872
4. DJ Kuter B Bain G Mufti A Bagg RP Hasserjian 2007 Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres Br J Haematol 139 3 351 362 10.1111/j.1365-2141.2007.06807.x 1:CAS:528:DC%2BD2sXhtlOhtL7M 10.1111/j.1365-2141.2007.06807.x 17910625 (Pubitemid 47512180)
5. P Bornstein 2001 Thrombospondins as matricellular modulators of cell function J Clin Invest 107 8 929 934 10.1172/JCI12749 1:CAS:528: DC%2BD3MXivVKjt70%3D 10.1172/JCI12749 11306593
6. P Bornstein 2009 Thrombospondins function as regulators of angiogenesis J Cell Commun Signal 3 3-4 189 200 10.1007/s12079-009-0060-8 10.1007/s12079-009- 0060-8 19798599
7. U Gianelli C Vener PR Raviele F Savi F Somalvico R Calori A Iurlo F Radaelli E Fermo P Bucciarelli S Bori G Coggi GL Deliliers 2007 VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders Am J Clin Pathol 128 6 966 973 10.1309/ FP0N3LC8MBJUFFA6 10.1309/FP0N3LC8MBJUFFA6 18024322
8. M Steurer H Zoller F Augustin D Fong S Heiss K Strasser-Weippl G Gastl A Tzankov 2007 Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor Hum Pathol 38 7 1057 1064 10.1016/j.humpath.2006.12.011 1:CAS:528:DC%2BD2sXmsFylsbg%3D 10.1016/j.humpath.2006.12.011 17442379 (Pubitemid 46899150)
9. HG Kopp AT Hooper MJ Broekman ST Avecilla I Petit M Luo T Milde CA Ramos F Zhang T Kopp P Bornstein DK Jin AJ Marcus S Rafii 2006 Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization J Clin Invest 116 12 3277 3291 10.1172/JCI29314 1:CAS:528:DC%2BD28XhtlWgsbnL 10.1172/JCI29314 17143334 (Pubitemid 44878642)
10. X Qian TN Wang VL Rothman RF Nicosia GP Tuszynski 1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells Exp Cell Res 235 2 403 412 10.1006/excr.1997.3681 1:CAS:528:DyaK2sXmtVygtr0%3D 10.1006/excr.1997.3681 9299165 (Pubitemid 27398399)
11. TA Wynn 2008 Cellular and molecular mechanisms of fibrosis J Pathol 214 2 199 210 10.1002/path.2277 1:CAS:528:DC%2BD1cXhvFCkt7w%3D 10.1002/path.2277 18161745 (Pubitemid 351160157)
12. H Chagraoui E Komura M Tulliez S Giraudier W Vainchenker F Wendling 2002 Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice Blood 100 10 3495 3503 10.1182/blood-2002-04-1133 1:CAS:528:DC%2BD38XoslKmtLc%3D 10.1182/blood-2002-04-1133 12393681 (Pubitemid 35303916)
13. TR Kyriakides P Rojnuckarin MA Reidy KD Hankenson T Papayannopoulou K Kaushansky P Bornstein 2003 Megakaryocytes require thrombospondin-2 for normal platelet formation and function Blood 101 10 3915 3923 1:CAS:528: DC%2BD3sXktVGntb0%3D 10.1182/blood.V101.10.3915 12732502 (Pubitemid 36857867)
14. A Tefferi JW Vardiman 2008 Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms Leukemia 22 1 14 22 10.1038/sj.leu.2404955 1:CAS:528:DC%2BD1cXmsV2jtA%3D%3D 10.1038/sj.leu.2404955 17882280
15. J Thiele HM Kvasnicka F Facchetti V Franco J van der Walt A Orazi 2005 European consensus on grading bone marrow fibrosis and assessment of cellularity Haematologica 90 8 1128 1132 16079113
16. O Bock J Neuse K Hussein K Brakensiek G Buesche T Buhr B Wiese H Kreipe 2006 Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status Am J Pathol 169 2 471 481 10.2353/ajpath.2006.060110 1:CAS:528:DC%2BD28XosFalu70%3D 10.2353/ajpath.2006.060110 16877349 (Pubitemid 44156308)
17. O Bock J Schlue U Lehmann R von Wasielewski F Langer H Kreipe 2002 Megakaryocytes from chronic myeloproliferative disorders show enhanced nuclear bFGF expression Blood 100 6 2274 2275 1:CAS:528:DC%2BD38Xnt1yht7w%3D 10.1182/blood-2002-06-1811 12229887 (Pubitemid 35001276)
18. W Kalas JL Yu C Milsom J Rosenfeld R Benezra P Bornstein J Rak 2005 Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras Cancer Res 65 19 8878 8886 1:CAS:528:DC%2BD2MXhtVKiu73N 10.1158/0008-5472.CAN-05-1479 16204059 (Pubitemid 41377377)
19. MM Krady J Zeng J Yu S MacLauchlan EA Skokos W Tian P Bornstein WC Sessa TR Kyriakides 2008 Thrombospondin-2 modulates extracellular matrix remodeling during physiological angiogenesis Am J Pathol 173 3 879 891 10.2353/ajpath.2008. 080128 1:CAS:528:DC%2BD1cXhtFCitL%2FL 10.2353/ajpath.2008.080128 18688033
20. SM Ribeiro M Poczatek S Schultz-Cherry M Villain JE Murphy-Ullrich 1999 The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta J Biol Chem 274 19 13586 13593 10.1074/jbc.274.19.13586 1:CAS:528:DyaK1MXjtFOlu7Y%3D 10.1074/jbc.274.19.13586 10224129 (Pubitemid 29220499)
21. TA Wynn 2007 Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases J Clin Invest 117 3 524 529 10.1172/JCI31487 1:CAS:528:DC%2BD2sXis12hsbY%3D 10.1172/JCI31487 17332879 (Pubitemid 46348506)
22. AS John X Hu VL Rothman GP Tuszynski 2009 Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion Exp Mol Pathol 87 3 184 188 10.1016/j.yexmp. 2009.09.002 1:CAS:528: DC%2BD1MXhtlyhtbbF 10.1016/j.yexmp.2009.09.002 19747478
23. O Bock M Muth K Theophile M Winter K Hussein G Busche N Kroger H Kreipe 2009 Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis Br J Haematol 146 5 510 520 10.1111/j.1365-2141.2009.07808.x 1:CAS:528:DC%2BD1MXhtFeqtLjP 10.1111/j.1365-2141.2009.07808.x 19604240
24. EM Cramer JM Masse JP Caen I Garcia J Breton-Gorius N Debili W Vainchenker 1993 Effect of thrombin on maturing human megakaryocytes Am J Pathol 143 5 1498 1508 1:CAS:528:DyaK2cXhsF2ktbc%3D 8238263
25. H Schulze M Korpal J Hurov SW Kim J Zhang LC Cantley T Graf RA Shivdasani 2006 Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis Blood 107 10 3868 3875 10.1182/blood-2005-07-2755 1:CAS:528:DC%2BD28XkvFWhur8%3D 10.1182/blood-2005-07-2755 16434494 (Pubitemid 43726790)
26. A Zaslavsky KH Baek RC Lynch S Short J Grillo J Folkman JE Italiano Jr. S Ryeom 2010 Platelet-derived thrombospondin-1 (TSP-1) is a critical negative regulator and potential biomarker of angiogenesis Blood 10.1182/blood-2009-09- 242065 20086246